A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III
Articles > Article · 2008
Authors: Sema KALKAN UÇAR, Mahmut ÇOKER, Eser YILDIRIM SÖZMEN, Ruhsar Damla GÖKŞEN, Şükran DARCAN
Nutrition, Metabolism and Cardiovascular Diseases, Journal Indexed in SCI Expanded, International, WoS, 2008, vol 19, pp 383-390
DOI: 10.1016/j.numecd.2008.09.005
Summary
Background and aims: Patients with glycogen storage disease type Ia (GSD Ia) and III (GSD III) do not develop premature atherosclerosis despite hyperlipidemia. The aim of the study was to investigate the oxidative-antioxidative conditions and high sensitivity C-reactive protein (hsCRP) levels in patients with glycogen storage disease type Ia and III.